Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice

BACKGROUND: Diabetes accelerates atherosclerosis through undefined molecular mechanisms. Hyperglycemia induces formation of advanced glycation end product (AGE)-modified low-density lipoprotein (LDL). Anti-AGE-LDL autoantibodies favor atherosclerosis (AS) progression in humans, while anti oxidized L...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lin, He, Zhiqing, Wu, Feng, Ding, Ru, Jiang, Qixia, Zhang, Jiayou, Fan, Min, Wang, Xing, Eva, Bengtsson, Jan, Nilsson, Liang, Chun, Wu, Zonggui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234834/
https://www.ncbi.nlm.nih.gov/pubmed/25391642
http://dx.doi.org/10.1186/s12933-014-0151-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234834/
https://www.ncbi.nlm.nih.gov/pubmed/25391642
http://dx.doi.org/10.1186/s12933-014-0151-6

Ejemplares similares